Combined treatment with CBIs and fasting blunted AKT phosphorylation in Capan-1 and HCT116 tumour xenografts, as well as in CRC tumour organoids (Fig. 6a and Supplementary Fig. 6a–c). This evidence concerns the gene AKT1 and neoplasm.